Cargando…
Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome
INTRODUCTION: Rapid spread of COVID-19 has caused detrimental effects globally. Involvement of the ACE2 receptor has identified COVID-19 as a multi-organ disease. Preliminary studies have provided evidence that cardiac involvement, including right ventricular dysfunction (RVD) and pulmonary hyperten...
Autores principales: | Oktaviono, Yudi Her, Mulia, Eka Prasetya Budi, Luke, Kevin, Nugraha, David, Maghfirah, Irma, Subagjo, Agus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479723/ https://www.ncbi.nlm.nih.gov/pubmed/36160328 http://dx.doi.org/10.5114/aoms/136342 |
Ejemplares similares
-
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis
por: Alsagaff, Mochamad Yusuf, et al.
Publicado: (2021) -
Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: a systematic review and meta-analysis
por: Ran, Liyu, et al.
Publicado: (2019) -
Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
por: Alsagaff, Mochamad Yusuf, et al.
Publicado: (2021) -
Inhaled prostacyclin analogues in COVID-19 associated acute respiratory distress syndrome: scientific rationale
por: Mulia, Eka Prasetya Budi, et al.
Publicado: (2021) -
Effect of Sacubitril/Valsartan on the Right Ventricular Function and Pulmonary Hypertension in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis of Observational Studies
por: Zhang, Jing, et al.
Publicado: (2022)